Tobacco use disorder and cardiovascular health

• Published in: Addiction (Abingdon, England) England), 2022-04, Vol.117 (4), p.1128-1138
• Main Authors: Benowitz, Neal L., Liakoni, Evangelia
• Format: Article
• Language: English
• Subjects: cardiovascular; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - epidemiology; cigarette; Cigarette smoking; Coronary artery disease; Drug therapy; Electronic Nicotine Delivery Systems; Health care management; heart; Heart diseases; Humans; Nicotine; Patients; Pharmacology; Reversible; Risk reduction; Smoking; Smoking Cessation; Tobacco; Tobacco Products; Tobacco Use Disorder - therapy
• ISSN: 0965-2140; 1360-0443; 1360-0443
• DOI: 10.1111/add.15703

This narrative review examines the impact of cigarette smoking and the use of other tobacco and nicotine products on cardiovascular disease. Smoking increases the incidence of both acute and chronic cardiovascular diseases, and the harmful effects are substantially and relatively quickly reversible after quitting. Recommended cessation treatment includes offering pharmacotherapy, counseling which should emphasize the rapid risk reduction that occurs after quitting and adequate follow‐up contacts. Although most research on cardiovascular disease in relation to tobacco use has focused upon cigarette smoking, we also review available data related to other combustible tobacco products, smokeless tobacco, electronic nicotine delivery systems and second‐hand smoke. We discuss the implications of smoking on clinical management of patients with heart disease and newer developments with potential relevance to treatment of such patients.